International Journal of Molecular Medical Science, 2025, Vol.15, No.2, 69-79 http://medscipublisher.com/index.php/ijmms 76 Incorporating FMH substances into the public health system can provide a more natural solution for disease prevention and control. 8.4 Industrialization development prospects The breakthroughs in modern biotechnology have created favorable conditions for the industrialization of FMH substances. The utilization of new biosynthesis technologies can achieve the environmentally friendly mass production of active ingredients in traditional Chinese medicine and promote the rational utilization of resources (Wang and Dai, 2023). The research on the synergistic effect of basic food components (such as protein and starch) can not only improve the sensory quality of products, but also enhance their functional characteristics (Tao, 2008). With the growth in the demand for natural functional products, the application prospects of FMH substances in the development of health foods and medicines are broad, and the research on the related mechanism of action is also continuously deepening. 9 Concluding Remarks Food and Medicine homologous substances (FMHS) have received extensive attention due to their dual roles in nutrition and treatment. Most of them are derived from traditional Chinese medicines and possess various activities such as anti-inflammation, anti-oxidation and anti-tumor. For instance, curcumin, the main component of turmeric, can regulate oxidative stress, inflammation and apoptosis, and is highly effective in the treatment of metabolic imbalances and immune diseases. Similarly, flavonoids in FMHS also exhibit excellent anti-inflammatory and antioxidant functions, which are of great significance for the prevention and treatment of chronic diseases. FMHS interacts with traditional drugs during the processes of absorption, distribution, metabolism and excretion, thereby affecting the efficacy and safety of the drugs. For instance, certain food components can alter the activity of enzymes and transport proteins in the intestinal tract, interfering with the body's processing of drugs. This indicates that understanding these interactions is very important for improving the medication regimen. The application potential of FMHS in the health industry is huge, and its usage scenarios have expanded to more emerging fields. The development of modern technologies such as network pharmacology and genomics has provided new methods for studying their mechanisms of action, while helping to identify new targets and promoting the development of safer and more effective products. Furthermore, machine learning technology provides new ideas for the discovery of new active ingredients in FMHS. By processing a large amount of FMHS compound information, the intelligent algorithm can quickly identify potential components that have inhibitory effects on important inflammatory enzymes (such as COX-2 and mPGES-1). This technology not only shortens the screening cycle but also enhances the reliability of identifying active ingredients. FMHS brings more natural solutions for disease prevention and control as well as health management. With the progress of scientific research and technological innovation, its role in the modern health system will continue to increase and it is expected to develop into an important pillar of the big health industry. Acknowledgments The author extend sincere thanks to two anonymous peer reviewers for their feedback on the manuscript. Conflict of Interest Disclosure The author affirms that this research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest. References Assadpour E., and Jafari S., 2019, A systematic review on nanoencapsulation of food bioactive ingredients and nutraceuticals by various nanocarriers, Critical Reviews in Food Science and Nutrition, 59(19): 3129-3151. https://doi.org/10.1080/10408398.2018.1484687 Briguglio M., Hrelia S., Malaguti M., Serpe L., Canaparo R., Dell’Osso B., Galentino R., Michele S., Dina C., Porta M., and Banfi G., 2018, Food bioactive compounds and their interference in drug pharmacokinetic/pharmacodynamic profiles, Pharmaceutics, 10(4): 277. https://doi.org/10.3390/pharmaceutics10040277
RkJQdWJsaXNoZXIy MjQ4ODYzNA==